Disappearance of steroid hormone dependency during malignant transformation of ovarian clear cell cancer

被引:30
作者
Akahane, Tomoko
Sekizawa, Akihiko
Okuda, Tsuyoshi
Kushima, Miki
Saito, Hiroshi
Okai, Takashi
机构
[1] Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa Ku, Tokyo 1428666, Japan
[2] Showa Univ, Sch Med, Dept Hosp Pathol, Tokyo 1428666, Japan
关键词
estrogen receptor; progesterone receptor; p53; c-erbB-2; ovarian clear cell carcinoma; ovarian endometrioid carcinoma; endometriosis; atypical endometriosis;
D O I
10.1097/01.pgp.0000165173.90339.a2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian clear-cell carcinoma (OCCA) and ovarian endometrioid carcinoma (OEMC) are often associated with endometriosis. This study determined the immunohistochemical expression of steroid hormone receptors and cancer-related genes in OCCA and OEMC specimens containing endometriosis and atypical endometriosis. Pathological progression from endometriosis to atypical endometriosis to carcinoma was identified in 4 of 22 OCCAs and 4 of 16 OEMCs. Using paraffin-cut bedded tissue samples, expression and changes in expression for estrogen receptors (ERs) and progesterone receptors (PRs) were examined in relation to the observed Pathological changes. A gradual reduction in ER alpha and PRA expression was observed with malignant transformation from endometriosis to atypical endometriosis to OCCA. In OEMC, ER alpha expression increased with malignant transformation. In conclusion, reductions in ER alpha and PRA expression were observed with progression from endometriosis to atypical endometriosis in OCCA specimens. Disappearance of hormone dependency might therefore be associated with malignant trans formation to OCCA.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 24 条
[1]   Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability [J].
Amemiya, S ;
Sekizawa, A ;
Otsuka, J ;
Tachikawa, T ;
Saito, H ;
Okai, T .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2004, 86 (03) :371-376
[2]  
CZERNOBILSKY B, 1979, OBSTET GYNECOL, V53, P318
[3]   Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis [J].
de la Cuesta, RS ;
Izquierdo, M ;
Cañamero, M ;
Granizo, JJ ;
Manzarbeitia, F .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2004, 113 (01) :87-93
[4]   Histologic transformation of benign endometriosis to early epithelial ovarian cancer [J].
DelaCuesta, RS ;
Eichhorn, JH ;
Rice, LW ;
Fuller, AF ;
Nikrui, N ;
Goff, BA .
GYNECOLOGIC ONCOLOGY, 1996, 60 (02) :238-244
[5]   Absence of estrogen receptor-α expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma [J].
Fujimura, M ;
Hidaka, T ;
Kataoka, K ;
Yamakawa, Y ;
Akada, S ;
Teranishi, A ;
Saito, S .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (05) :667-672
[6]   Ovarian atypical endometriosis: Its close association with malignant epithelial tumours [J].
Fukunaga, M ;
Nomura, K ;
Ishikawa, E ;
Ushigome, S .
HISTOPATHOLOGY, 1997, 30 (03) :249-255
[7]   Microsatellite DNA assays reveal an allelic imbalance in p16Ink4, GALT, p53, and APOA2 loci in patients with endometriosis [J].
Goumenou, AG ;
Arvanitis, DA ;
Matalliotakis, IM ;
Koumantakis, EE ;
Spandidos, DA .
FERTILITY AND STERILITY, 2001, 75 (01) :160-165
[8]   P53 IN TUMOR PATHOLOGY - CAN WE TRUST IMMUNOHISTOCHEMISTRY - REVISITED [J].
HALL, PA ;
LANE, DP .
JOURNAL OF PATHOLOGY, 1994, 172 (01) :1-4
[9]   HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway [J].
Herrmann, F ;
Lehr, HA ;
Drexler, I ;
Sutter, G ;
Hengstler, J ;
Wollscheid, U ;
Seliger, B .
CANCER RESEARCH, 2004, 64 (01) :215-220
[10]   p53 mutation is infrequent in clear cell carcinoma of the ovary [J].
Ho, ESC ;
Lai, CR ;
Hsieh, YT ;
Chen, JT ;
Lin, AJ ;
Hung, MJ ;
Liu, FS .
GYNECOLOGIC ONCOLOGY, 2001, 80 (02) :189-193